PROX1 and breast cancer: Zhao et al. demonstrated increased Prox-1 and LYVE-1 mRNA in uninvolved SLN of BC patients in comparison to control lymph nodes via quantitative real-time RT-PCR, with higher expression levels in patients with high VEGF-C expressing tumors [14].